2 results
Approved WMOCompleted
Primary objective:To demonstrate the efficacy of Rifaximin -EIR 400 mg Tablet (800mg /BID, total daily dose 1600 mg) versus placebo in the prevention of endoscopic Crohn*s disease recurrence following ileocolonic resection
Approved WMORecruiting
To determine the (cost)effectiveness of OTHER (Occupational Therapy at Home E-Rehabilitation), as compared to usual OT, on improving the self-perceived performance in daily activities of community-dwelling older persons post-stroke over a 24-week…